Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PUVA and cancer: a case-control study

B Lindelöf1, B Sigurgeirsson

  • 1Department of Dermatology, Karolinska Hospital, Stockholm, Sweden.

The British Journal of Dermatology
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.

The British journal of dermatology·2020
Same author

A survey among dermatologists: diagnostics of superficial fungal infections - what is used and what is needed to initiate therapy and assess efficacy?

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response.

The British journal of dermatology·2017
Same author

Secukinumab re-initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis.

The British journal of dermatology·2017
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
Same journal

Clinicopathological features of lymphocytic thrombophilic arteritis and the relationship with livedoid vasculopathy - a case series of 36 patients.

The British journal of dermatology·2026
Same journal

Improving Prognostication for Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Recurrent and novel GLTP variants in five patients with nonsyndromic epidermal differentiation disorder: phenotypic and genotypic expansion.

The British journal of dermatology·2026
See all related articles

Methotrexate therapy may increase skin cancer risk in patients treated with PUVA (psoralen plus ultraviolet A). This study found a significant association between prior methotrexate use and squamous cell carcinoma in PUVA-treated individuals.

Area of Science:

  • Dermatology
  • Oncology
  • Photomedicine

Background:

  • Psoralen plus ultraviolet A (PUVA) therapy is used for skin conditions.
  • Skin cancer is a potential long-term risk associated with PUVA treatment.
  • Identifying co-carcinogens is crucial for patient safety.

Purpose of the Study:

  • To investigate potential co-carcinogens for skin cancer in PUVA-treated patients.
  • To assess the association between prior therapies and squamous cell carcinoma development.
  • To determine if methotrexate is a risk factor for skin cancer in this population.

Main Methods:

  • A case-control study design was employed.
  • 24 patients with squamous cell carcinoma post-PUVA treatment were compared to 96 matched controls.

Related Experiment Videos

  • Prior therapies including tar, ultraviolet-B, ionizing radiation, methotrexate, and arsenic were analyzed.

    • Main Results:

    • Prior methotrexate therapy showed a statistically significant association with squamous cell carcinoma.
    • The relative risk of skin cancer associated with prior methotrexate was 3.5 (95% CI: 1.2-9.9).
    • No significant associations were found for other investigated co-carcinogens.

    Conclusions:

    • Prior methotrexate therapy may be a significant risk factor for developing skin cancer in PUVA-treated patients.
    • Further research is warranted to confirm this association and elucidate mechanisms.
    • This finding has implications for risk assessment and patient management in phototherapy.